AzTrials
AzTrials

STINot'ISTNCT04921618

Partner Notification of Sexually Transmitted Infections (STIs) in Testing Centers

An observational study of STI and Hiv, run by ANRS, Emerging Infectious Diseases at 9 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Since the 2000s, the incidence of bacterial STIs increases, mainly among men who have sex with men but also among heterosexual men and women with multiple sexual partners. A partner notification (PN) approach could break transmission chains and curb STI epidemics. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
STI, Hiv
What is being tested?
2 online self-administered questionnaires on
How many people
2,200 participants
Where
9 sitesFrance
Study dates
12 Jul 2021to Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Two distinct populations will be studied * People diagnosed with >= 1 STI in testing centers or sexual health clinics: index patients, * People attenting testing centers or sexual health clinics for STI testing and/or access to treatment following notification of possible exposure to an STI by one of their partners: notified partners. Index patients and notified partners will be included on a voluntary basis. The study will be offered to all eligible individuals during the study period.

Who may be able to join

  • For index patients
  • Diagnosed with at least one bacterial STI, and/or HIV and/or acute HCV at one of the participating centers during the study period,
  • Aged >= 18,
  • Agree to participate in the study after oral and written information.
  • For notified partners
  • Attend one of the participating centers during the study period, within 6 months of being notified of their exposure to an STI (bacterial STI, and/or HIV and/or acute HCV) by one of their partners, who is infected with one or more of these STIs,
Show all 12Show fewer
  • Aged >= 18,
  • Agree to participate in the study after oral and written information.
  • Non-Inclusion Criteria:
  • For index patients and notified partners
  • People who do not read or speak French,
  • Wardship or curatorship adults.

Who cannot join

None listed.

Trial locations and contacts

9 sites in 1 country.

9 sites in 1 country

France9 sites, 9 recruiting
  • CeGIDD d'Aix-en-Provence

    Aix-en-Provence

    Dominique AYMAR-MOULENE, Dr, 04 13 31 84 69, dominique.aymarmoulene@departement13.fr

    Recruiting
  • CeGIDD de Caen

    Caen

    Caroline GALIMARD, Dr, 02 31 38 51 58, cpmi@fondation-misericorde.fr

    Recruiting
  • CeGIDD de Lille

    Lille

    Laetitia RANDOUX, Dr, 03 59 73 69 80, laetitia.randoux@lenord.fr

    Recruiting
  • CeGIDD - La Joliette

    Marseille

    Julie SAULE, Dr, 04 13 31 69 14, julie.saule@departement13.fr

    Recruiting
  • CeGIDD - Saint Adrien

    Marseille

    Jean-Luc ROBERT, Dr, 04 13 31 56 78, jeanluc.robert@departement13.fr

    Recruiting
  • CeGIDD de Bichât

    Paris

    Jade GHOSN, Pr, 01 40 25 84 34, jade.ghosn@aphp.fr

    Recruiting
  • CeGIDD de La Pitié Salpêtrière

    Paris

    Gentiane MONSEL, Dr, 01 42 17 70 12, gentiane.monsel@aphp.fr

    Recruiting
  • Centre de santé sexuelle - LE 190

    Paris

    Michel OHAYON, Dr, 01 55 25 32 72, mohayon@le190.fr

    Recruiting
  • Institut Alfred Fournier

    Paris

    William TOSINI, Dr, 01 40 78 26 00, william.tosini@institutfournier.org

    Recruiting

Other trials in France

About this study

Official title: Towards Improving Information, Testing and Treatment for Partners of People Diagnosed With STIs in Testing Centres and Sexual Health Clinics, the Not'IST Study

Since the 2000s, the incidence of bacterial STIs increases, mainly among men who have sex with men but also among heterosexual men and women with multiple sexual partners. A partner notification (PN) approach could break transmission chains and curb STI epidemics. PN brings together a set of interventions to help people diagnosed with STIs to inform their partners, encourage them to get tested, so that they can access treatment or prevention. A PN approach, systematically offered at STI diagnosis, has not yet been implemented in France and needs to be evaluated. In 2018, the Conseil National du Sida (French National AIDS Council) stated in favor of a formalized PN approach, particularly in testing centers, which carry out a large part of STI diagnoses.

The aim of our research project is to build interventions facilitating information, testing and treatment of partners of people diagnosed with STIs in testing centers and sexual health clinics.

Read more

Step 1: A cross-sectional study

Primary objective

To describe the PN practices of people diagnosed with an STI in testing centers and sexual health clinics without any intervention

Secondary objectives

  • To describe the profiles of people diagnosed with an STI in testing centers or sexual health clinics and therefore likely to receive an intervention to help them notify their partners;
  • To describe the profiles of people notified by their partners and who attend testing centers or sexual health clinics for STI testing;
  • To describe the notification received by these notified partners and identify the facilitators of testing use following notification.

Step 2: A qualitative study

Objectives

  • To evaluate the acceptability of testing center staff for an STI notification program in general and discuss the feasibility of interventions pre-identified by a literature review;
  • In a collaborative (researchers and staffs) approach, to adapt these interventions to (1) the testing centers working and (2) the needs of their users identified in the cross-sectional study.

Expected results

This study is the first step in implementation of a PN program as part of a comprehensive management of STI diagnoses in France.

Read the detailed description

Methods

Step 1: A cross-sectional study

Cross-sectional study conducted in testing centers and sexual health clinics (6 centers, 6 months of enrollment), targeting two populations:

  • People aged 18 years or more diagnosed for at least one STI: the index patients;
  • People aged 18 years or more attending the same centers for STI testing after being notified by a sexual partner: the notified partners.

This study is based on 3 online self-administered questionnaires:

  • A questionnaire, the same for index patients and notified partners, collecting socio-demographic profile, health care and testing use, STI history and sexual behavior;
  • A questionnaire for index patient on spontaneous PN practices of index patients one month after STI diagnosis, including types of partners notified, methods used to notify, and reasons for not notifying partners (this questionnaire will be sent one month after STI diagnosis to give participants the time to inform their partners);
  • A questionnaire for notified partner on their experience of PN, such as the type of notifying partner, the methods and information transmitted during notification, their feelings and what led them to get testing after being notified.

A notified partner diagnosed with an STI will receive also the questionnaire on spontaneous practices of index patients at M1. This will allow us to observe whether people who had already been notified for an STI are more likely to notify their partners.

Step 2: A qualitative study

Focus-groups of 6-8 volunteers involved in STI testing in testing centers and sexual health clinics will be conducted based on an interview guide. Doctors and other staffs will be interviewed separately.

Thematic analysis

Conditions
STI, Hiv
Being tested
2 online self-administered questionnaires on
Keywords
partner notification, STI, HIV, testing center, intervention design
Medical subject headings
Sexually Transmitted Diseases, Acquired Immunodeficiency Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 2 online self-administered questionnaires onOther

    1. Participant profile
    2. Spontaneous partner notification practices collected one month after STIs diagnosis
  • 2 online self-administered questionnaires onOther

    1. Participant profile
    2. Experiences with partner notification and use of STI testing following notification
Study groups in NCT04921618
Study groupRoleWhat they receive
Index patientsPeople aged 18 or more diagnosed with >= 1 STI in testing centers. [STI = bacterial STIs and/or HIV and/or acute hepatitis C virus (HCV)]
Receives: Other: 2 online self-administered questionnaires on
Notified partnersPeople aged 18 or more getting STI testing in testing centers after being notified by a sexual partner. [STI = bacterial STIs and/or HIV and/or acute HCV]
Receives: Other: 2 online self-administered questionnaires on

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Partner notification by index patients

    Proportion of index patients who notified at least one sexual partner one month after their STI diagnosis

    Measured: One month after STI diagnosis

Secondary outcomes (2)
  1. Partners notified by index patients

    Mean proportion of notified partners among partners reported by index patients

    Measured: One month after STI diagnosis

  2. Notified partners tested positive

    Proportion of notified partners tested positive among notified partners attending STI testing

    Measured: At notified partners inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2021
  2. Study start12 Jul 2021
  3. Primary completionDec 2022 (estimated)
  4. Study completionDec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
2,200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04921618
Sponsor's protocol ID
ANRS MIE Not'IST
Acronym
Not'IST
Status last verified
Jul 2022
First submitted
27 Apr 2021
Last updated
25 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of STI and Hiv, run by ANRS, Emerging Infectious Diseases at 9 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Partner notification by index patients (time frame: One month after STI diagnosis). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in